Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults
Ioannis Politikos(Beth Israel Deaconess Medical Center), Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Corey Cutler(Harvard University), Theodoros Karantanos(Johns Hopkins University), Haesook T. Kim(Dana-Farber Cancer Institute), Karen K. Ballen(University of Virginia Health System), Joseph H. Antin(Dana-Farber Cancer Institute), Julia A. Brown(Cornell University), Le‐Qun Li(Beth Israel Deaconess Medical Center), Sean M. McDonough(Harvard University), Jerome Ritz(Dana-Farber Cancer Institute)
Cited by 7
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k